Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hepatic gluconeogenic enzymes are a set of key enzymes primarily found in the liver that catalyze essential steps in gluconeogenesis, the process by which glucose is synthesized from non-carbohydrate precursors. These enzymes, including pyruvate carboxylase (PC), phosphoenolpyruvate carboxykinase (PEPCK), fructose-1,6-bisphosphatase (FBP1), and glucose-6-phosphatase (G6PC), bypass the irreversible steps of glycolysis, allowing for the net production of glucose. They are tightly regulated by hormones and allosteric effectors to maintain blood glucose homeostasis, and their dysregulation is implicated in metabolic disorders like diabetes.
Regulation of enzyme activity and gene expression involved in hepatic glucose production.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hepatic Gluconeogenic Enzymes.